MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,248,970 | +255.8% | 27,565 | +448.0% | 0.01% | +300.0% |
| Q3 2022 | $351,000 | -23.5% | 5,030 | -9.9% | 0.00% | 0.0% |
| Q1 2022 | $459,000 | -43.1% | 5,584 | +11.8% | 0.00% | -50.0% |
| Q2 2021 | $807,000 | +31.0% | 4,996 | +38.9% | 0.01% | 0.0% |
| Q1 2021 | $616,000 | -47.8% | 3,596 | -33.0% | 0.01% | -50.0% |
| Q4 2020 | $1,180,000 | +187.1% | 5,371 | +49.0% | 0.01% | +140.0% |
| Q2 2020 | $411,000 | – | 3,604 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |